bioMérieux S.A. (EPA:BIM)
74.35
+1.10 (1.50%)
May 29, 2026, 5:35 PM CET
bioMérieux Market Cap
bioMérieux has a market cap or net worth of €8.77 billion as of May 29, 2026. Its market cap has decreased by -37.56% in one year.
Market Cap
8.77B
Enterprise Value
8.67B
Revenue
4.07B
Ranking
n/a
PE Ratio
22.26
Stock Price
€74.35
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.18B to 8.77B, an increase of 640.94%. That is a compound annual growth rate of 9.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 8.77B | -32.66% |
| Dec 31, 2025 | 13.02B | 6.63% |
| Dec 31, 2024 | 12.21B | 2.78% |
| Dec 29, 2023 | 11.88B | 2.52% |
| Dec 30, 2022 | 11.59B | -21.58% |
| Dec 31, 2021 | 14.78B | 8.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 90.36B |
| EssilorLuxottica Société anonyme | 80.52B |
| Sartorius Stedim Biotech | 17.33B |
| Ipsen | 12.86B |
| Eurofins Scientific SE | 10.97B |
| ABIVAX Société Anonyme | 9.04B |
| Virbac | 3.00B |
| emeis Société anonyme | 2.40B |